Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
Australia's medical technology: just what the doctor ordered.

Download PDFDownload PDF

The Hon Simon Crean MP Minister for Trade


Media contact: David Garner (Mr Crean’s Office) 02 6277 7420 / 0400 412 404

Austrade (02) 9390 2388/ 0434 567 673

SC092 14 November 2008


“Australia’s $1.6 billion medical technology industry will showcase its distinct competitive advantages at the world’s largest medical fair, MEDICA , in Germany next week” said the Minister for Trade, Simon Crean.

The global medical devices industry is estimated to be worth US$174 billion and is growing at around 10% per annum.

“Australia is internationally recognised for the quality of our medical research and development,” Mr Crean said.

“Australian medical discoveries have improved the quality of health for people across the world. These include the curative effects of penicillin, the development of the cochlear implant, the cervical cancer vaccine (Gardasil), and sleep apnea devices (ResMed).

“Our highly skilled workforce is greatly acclaimed, with nine Australians awarded a Nobel Prizes for work in medicine and related fields. We are ranked number one when compared to competitor countries as a location to conduct clinical trials.

“We have many global advantages including offering reduced time to market compared with drug discovery, and a close geographic proximity within the economically dynamic Asia Pacific region.

“Australia’s products and services are also characterised by their quality, safety and cost effectiveness which is determined by our regulatory body (Therapeutic and Goods Administration).It ensures our medical devices meet the highest standards. These aspects will stand this industry in good stead in the current uncertain economic climate.”

Austrade, the Australian Government’s trade and investment development agency, will be helping to showcase Australian expertise at MEDICA, in Dusseldorf, Germany.

“The 30 innovative Australian companies heading to MEDICA will get to demonstrate their products to a phenomenal audience of 137,000 trade visitors representing around 100 countries,” said Mr Crean.

“It’s a fantastic opportunity for these businesses to meet interested buyers, find new partners, negotiate sales and analyse the international competition.”

Some of the participants include;

• Diversionary Therapy Technologies (QLD)- the portable console is a tool which aims to reduce anxiety related pain, specifically for children during traumatic medical procedures.

Page 2

Media contact: David Garner (Mr Crean’s Office) 02 6277 7420 / 0400 412 404

Austrade (02) 9390 2388/ 0434 567 673

• Rye Pharmaceuticals (trading as BurnAid) (NSW) - sterile hydrogel burn dressings, gels, and various kits

• Yeescope (NSW)- world's first disposable laryngoscope that helps to reduce the chances of infection

• Delvtech (QLD)- mobile medical devices. Patented technologies enable many medications to be delivered on-demand via inhalation.

• ASP Healthcare (NSW)- personal sharps containers and kits

• Mediplas (VIC) - high quality adult and neonatal plastic respiratory components and equipment.

“Austrade will also be launching Australian Health and Medical 2009-a capability directory to showcase to an international audience medical technology, products and services from approximately 100 Australian suppliers.” Mr Crean said.